© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
February 09, 2022
A panel of eye care specialists share clinical advice and future directions for the treatment of wet AMD.
Dante J. Pieramici, MD; Roger A. Goldberg, MD, MBA; and Lloyd Clark, MD, review novel compounds in development for the treatment of wet AMD.
Dante J. Pieramici, MD, leads the discussion on potential safety issues of anti-VEGF agents and addressing these concerns with patients who have wet AMD.
February 02, 2022
A panel of eye care specialists review challenges faced with the management of wet AMD when patients are put on an extended treatment regimen.
David B. Glasser, MD: The Larger Implications of Telehealth in Ophthalmology
Inequities Continue to Exist in Ophthalmology Care
Postoperative Macular Hole Outcomes Benefit from Vitrectomy Without Delay